Whole Mount Immunofluorescent Staining of the Neonatal Mouse Retina to Investigate Angiogenesis In vivo

Summary

The neonatal murine retina provides a well characterized physiological model of angiogenesis, which permits investigations of the roles of different genes or drugs that modulate angiogenesis in an in vivo context. Immunofluorescent staining to accurately visualize the vascular plexus is pivotal to the success of these types of studies.

Abstract

Angiogenesis is the complex process of new blood vessel formation defined by the sprouting of new blood vessels from a pre-existing vessel network. Angiogenesis plays a key role not only in normal development of organs and tissues, but also in many diseases in which blood vessel formation is dysregulated, such as cancer, blindness and ischemic diseases. In adult life, blood vessels are generally quiescent so angiogenesis is an important target for novel drug development to try and regulate new vessel formation specifically in disease. In order to better understand angiogenesis and to develop appropriate strategies to regulate it, models are required that accurately reflect the different biological steps that are involved. The mouse neonatal retina provides an excellent model of angiogenesis because arteries, veins and capillaries develop to form a vascular plexus during the first week after birth. This model also has the advantage of having a two-dimensional (2D) structure making analysis straightforward compared with the complex 3D anatomy of other vascular networks. By analyzing the retinal vascular plexus at different times after birth, it is possible to observe the various stages of angiogenesis under the microscope. This article demonstrates a straightforward procedure for analyzing the vasculature of a mouse retina using fluorescent staining with isolectin and vascular specific antibodies.

Introduction

Angiogenesis is a complex developmental process defined by the formation of new blood vessels from a pre-existing vessel network and is regulated by several signalling pathways. The most prominent of these is the VEGF pathway. VEGF is released by ischemic cells and leads to the initiation of angiogenic sprouting in neighboring blood vessels. The leading endothelial cell from a new vascular sprout is a 'tip' cell, which produces filopodia that reach out towards the source of VEGF, and is followed by proliferating 'stalk' endothelial cells. In this way, activated endothelial cells migrate and proliferate towards an avascular region where they form new vascular tubes. In order to stabilize these tubes to support blood flow, endothelial cells interact with pericytes and smooth muscle cells, which surround the new blood vessels ¹. Angiogenesis is essential for vascularization of the embryo and growing tissues. However, it also contributes to many pathological disorders such as cancer; whereas defects in angiogenesis are associated with ischemic diseases. The development of effective drug treatments to regulate angiogenesis as a means of treating disease is therefore of great interest. For example, effective anti-angiogenic factors will reduce cancer growth, whilst pro-angiogenic strategies can be used to treat ischemic disease. Thus, models of angiogenesis are essential to better understand the regulation of new vessel formation and for developing new therapeutic strategies to enhance or decrease vascular growth.

A fundamental element of angiogenesis research is the choice of an appropriate vascular model. Many in vitro models have been designed to reproduce the basic steps of angiogenesis such as endothelial cell migration, proliferation and survival ^2,3 . A frequently used in vitro assay is the formation of a branched network of endothelial cells on a Matrigel matrix, although this is not specific for endothelial cells, nor does it usually incorporate the support of pericytes or smooth muscle cells. Assessment of ex vivo sprouting angiogenesis using mouse organ culture such as the embryoid body assay, the aortic ring assay and the fetal metatarsal assay allows the analysis of angiogenesis of endothelial cells in the context of additional supporting cells. However, the main limitations of these assays include the lack of blood flow and the regression of vessels over time, giving a limited window for analysis. Therefore, to understand the regulation of angiogenesis more accurately, in vivo models are required such as those developed in mouse using subcutaneously implanted sponges or matrigel plugs, as well as the hind limb ischemia model. However, these models are challenging to analyze due to the complex 3D architecture of the neovessels. In contrast, the zebrafish embryo has proved an excellent model for visualizing angiogenesis in the whole organism ⁴. However, the mouse is evolutionarily much more closely related to human than zebrafish, making the mouse a preferred model in many cases. Consequently angiogenesis of the postnatal mouse retina represents a well characterized method of choice for angiogenesis research. It not only provides a physiological setting, but also a 2D vascular plexus that can be readily visualized using appropriate fluorescent stains. The architecture of the vessel network, endothelial proliferation, sprouting, perivascular cell recruitment and vessel remodelling can all be investigated using this technique.

In the neonatal mouse retina, development of retinal blood vessels occurs in the first week of postnatal life. Mice, unlike humans, are born blind and the retinas only become vascularized after birth. Retinal vessels arise from the center of the retina close to the optic nerve at postnatal day 0 (P0), and develop by angiogenesis to form a highly organized vascular plexus that reaches the retinal periphery by approximately P8 ⁵. Blood vessels develop in a characteristic manner with the capillary plexus gradually growing outward from the optic disc toward the periphery to generate a regular alternating pattern of arteries and veins with an intervening capillary network. The retinal vasculature provides an ideal model to study angiogenesis as the vessels can be easily identified as they grow in what is essentially a 2D plane, thus making it relatively easy to examine the retinal vasculature in flat-mount preparations ⁵. A method for isolating the mouse neonatal retina for analysis of endothelial tip cell responses over several hours ex vivo has been reported ⁶. Alternatively, a more detailed investigation of the whole retinal vasculature and associated vascular markers requires immunostaining of fixed retina specimens at different stages of development.

Here we provide a detailed description of a reliable and technically straight forward method that we use for whole mount staining of the murine retinal vascular plexus, from the initial enucleation of the postnatal eye (see also ⁷) through the staining protocols to final imaging under the microscope.

Protocol

All steps are performed at room temperature, unless otherwise indicated.

1. Enucleation and Fixation of Postnatal Eyes

1. Place humanely killed mouse pup on its side, remove the skin covering the eye with scissors.
2. Use scissors and forceps to enucleate the eye.
3. Place scissors below the enucleated eye, cut the optic nerve and surrounding tissues and lift out the eye. Transfer to a 24-well plate containing 4% paraformaldehyde (PFA) made up in 2x PBS at room temperature.
4. Allow each eye to fix for 10 - 15 min, then transfer to cold 2x PBS on ice for 5 - 10 min. It is best to stagger enucleations and subsequent fixation to ensure the degree of fixation is equal for each eye.

2. Dissection of Postnatal Murine Retinas

1. Transfer eyes into a Petri dish containing 2x PBS using a plastic Pasteur pipette that has been cut to widen the bore and place under a dissecting microscope.
2. Remove any fat around the eye using forceps and scissors.
3. Pierce the edge of the cornea with sharp scissors and cut around the cornea and iris and discard.
4. Insert forceps between retina and sclera and remove the sclera taking care not to tear the retina. The choroid layer can also be removed, but if there is a risk of damage to the retina occurring during this step, the choroid layer can be left on as it should not significantly affect the quality of the immunostaining.
5. Remove the lens and the vitreous humour using forceps.
6. Remove the hyaloids vessels by gathering them together in the center of the eye with fine forceps then quickly pull away from the center of the retina (alternatively snip at base of hyaloid vessels with fine scissors).
7. Rinse the cup shaped retina with PBS in a clean Petri dish.
8. Make 4 to 5 radial incisions reaching approximately 2/3 of the radius of the retina using spring scissors to create a 'petal' shape.
9. Draw off PBS using a Pasteur pipette to flatten the retina, and then remove any excess PBS with a small piece of absorbent paper.
10. Slowly pipette cold (-20 °C) methanol drop by drop onto surface of retina until totally covered and then flood with additional methanol. This will help to fix the retinas and will facilitate permeabilization. The retinas will turn white.
11. Transfer to a 2 ml tube using a plastic Pasteur pipette that has been cut to widen the bore.
12. Leave retina in cold methanol for at least 20 min before proceeding with immunostaining. Of the antibodies used here, only VE-Cadherin cannot be used successfully on methanol fixed retinas. In this case retinas need to proceed straight to immunostaining after step 9.
13. If required, retinas can be stored in methanol at -20 °C for up to several months prior to staining.

3. Immuno/isolectin Staining of the Retinal Vasculature

1. Carefully remove/pour off methanol and gently rinse retinas briefly in PBS (at this stage the retina is still in the same 2 ml tube from step 11 above).
2. Remove PBS and cover retinas with 100 μl of Perm/Block solution (PBS + 0.3% Triton + 0.2% BSA) + 5% of appropriate serum (see Table 1) and shake gently for 1 hr.
3. Remove Perm/Block and incubate retinas with gentle shaking overnight at 4 °C with 100 μl of selected primary antibodies (see Table 1) and/or IsolectinB4, all prepared by diluting in Perm/Block.
4. Remove antibody/isolectin and wash retinas 4 x 10 min in PBS + 0.3% Triton (PBSTX).
5. In some cases, e.g. following staining with IsolectinB4-Alexa488 or a directly conjugated primary antibody, a secondary antibody is not required and retinas can be mounted directly (step 7). When an unconjugated primary antibody has been used in step 3, then 100 μl of the appropriate fluorescent secondary antibody (diluted 1/200 in PBSTX) is added and left to incubate overnight at 4 °C or for 4 hr at room temperature.
6. Remove secondary antibody and wash retinas 4 x 15 min in 2 ml PBSTX.
7. Transfer retinas onto slides using a wide bore plastic Pasteur pipette and remove excess PBSTX with absorbant tissue. Mount retinas by adding 50 μl of Prolong mountant onto a coverslip and gently position over the retina.
8. Transfer slides to fridge overnight at 4 °C, ensuring that they are flat and protected from light, to allow the Prolong mountant to set.
9. Image retina using a confocal microscope or an epifluorescence microscope.

Results

After dissection the retina should look like a flat flower (Figure 1). By using the protocol, outlined above, endothelial cells can be seen using isolectin B4-Alexa488 staining and supporting vascular muscle cells are visualized using anti-alpha smooth muscle actin (Figure 2). The low power view using a 5X objective in Figure 2 allows an overview of the vascular organization of the retina. Also, by using a different combination of antibodies given in the protocol above, ...

Discussion

The method presented here offers a simple and efficient way to obtain images of stained whole mount preparations of neonatal mouse retinas, making it an easily quantifiable and physiologically relevant model of angiogenesis. Initially, the mouse eye can be quite difficult to dissect due to its small size and globe shape, so some practice and good dissection tools are needed for reliable results. Dissection of eyes prepared in 2x concentration of PBS is important because this causes a small amount of water loss from the e...

Materials

List of materials used in this article

Name	Company	Catalog Number	Comments
Material
Plastic pipettes 3 ml	Scientific Laboratory Supplies	PIP4210	Remove tip with scissors to create a wide bore
BD Falcon 24-well plates	Scientific Laboratory Supplies	353226
Select Petri dishes TV 90 mm	Scientific Laboratory Supplies	SLS2002
Histobond slides	VWR	631-0624
Coverslips 22 x 22 mm	VWR	631-1336
Dumont Tweezers #5	World precision instruments	14095
Spring scissors 10.5 cm long, with straight 8 mm blades	World precision instruments	501235	Used for enucleation
Vannas scissors 8.5 cm long, with straight 7 mm blades, and 0.025 x 0.015 mm superfine tips	World precision instruments	500086	Used for dissecting retina
Superfine vannas scissors 8 cm long with straight 3 mm blades, and 0.015 x 0.015 mm superfine tips	World precision instruments	501778	Used for dissecting retina
crystal clear’ tubes 2 ml	Starlab	E1420-2000
Reagents
Sodium phosphate dibasic	Sigma	S0876	PBS reagent
Potassium phosphate monobasic	Sigma	P5655	PBS reagent
Sodium chloride	Sigma	S9625	PBS reagent
Paraformaldehyde	Sigma	P6148	Make up in 2x PBS and store at -20 °C
BSA	Sigma	A7638
Triton X-100	Sigma	T9284
Donkey serum	Sigma	D9663
Goat serum	Vector	S-1000
Prolong Gold anti-fade reagent	Invitrogen	P36930	Mounting reagent
Isolectin GS-IB4-alexa 594	Invitrogen	I21413	Use at 1:200 dilution
Isolectin GS-IB4-alexa 488	Invitrogen	I21411	Use at 1:200 dilution
Primary Antibodies
Anti-NG2 (rabbit polyclonal )	Millipore	AB5320	Detects pericytes
Anti-GFAP (clone GA5, mouse monoclonal)	Millipore	MAB360	Detects astrocytes
Anti-Desmin (clone Y66, rabbit monoclonal)	Millipore	04-585	Detects pericytes
Anti-Collagen IV (rabbit polyclonal )	Chemicon	AB756P	Detects vascular basement membrane
Anti-alpha smooth muscle actin-Cy3 (clone 1A4, mouse monoclonal)	Sigma	C6198	Detects vascular smooth muscle cells.
Anti-Endoglin (clone MJ7/18, rat monoclonal)	BD Pharmingen	550546	Detects endothelial cells
Anti-CD31 (clone MEC13.3, rat monoclonal)	BD Pharmingen	553370	Detects endothelial cells
Anti-VE-Cadherin (clone 11D4.1, rat monoclonal)	BD Pharmingen	550548	Detects endothelial cell junctions
Anti-Alk1 (goat polyclonal)	R&D Systems	AF770	Detects endothelial cells
Secondary Antibodies
Goat anti-rabbit-Alexa594	Invitrogen	A11012	All secondary antibodies are aliquoted immediately on arrival and stored at -20 °C.
Goat anti-rat-Alexa488	Invitrogen	A11006	All secondary antibodies are aliquoted immediately on arrival and stored at -20 °C.
Goat anti-rat-Alexa594	Invitrogen	A11007	All secondary antibodies are aliquoted immediately on arrival and stored at -20 °C.
Goat anti-mouse-Alexa488	Invitrogen	A11029	All secondary antibodies are aliquoted immediately on arrival and stored at -20 °C.
Donkey anti-goat-Alexa594	Invitrogen	A11058	All secondary antibodies are aliquoted immediately on arrival and stored at -20 °C.
Microscopes
Dissection microscope	Zeiss	Stemi SV6
Camera	Zeiss	Axiocam HRc	Camera for dissection microscope
Epifluorescent Microscope	Zeiss	Axioimager with Apotome
Camera	Zeiss	Axiocam HRm	Camera for Axioimager
Confocal Microscope	Nikon	A1R